Critical Appraisal of Guidelines for Daytime Urinary Incontinence in Children: Evaluation of Quality and

J Marleen Linde1,2, Ilse Hofmeester3, Martijn G Steffens2

  • 1Department of Primary and Long-term Care, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.

PubMed

Insights

This study evaluated guidelines for childhood non-neurogenic daytime urinary incontinence (DUI). Only two of eight guidelines met quality standards, highlighting the need for improved development using tools like AGREE II.

Area of Science:

  • Pediatric Urology
  • Clinical Guideline Evaluation
  • Evidence-Based Medicine

Background:

  • Non-neurogenic daytime urinary incontinence (DUI) in children is a common condition.
  • Existing clinical practice guidelines for managing childhood DUI vary in quality.
  • A systematic assessment of these guidelines is needed to inform clinical practice.

Purpose of the Study:

  • To evaluate the quality of current guidelines for non-neurogenic daytime urinary incontinence (DUI) in children.
  • To compare the content of these guidelines regarding the assessment of children with DUI.
  • To provide recommendations for improving guideline development and selection.

Main Methods:

  • Systematic literature search for guidelines on childhood non-neurogenic DUI.
  • Quality assessment using the Appraisal of Guidelines for Research and Evaluation II (AGREE) instrument.
  • Descriptive comparison of diagnostic recommendations across included guidelines.

Main Results:

  • Eight guidelines were included, with overall quality scores ranging from 2.6 to 5.8 (out of 7).
  • Three guidelines were rated good, four moderate, and one low quality.
  • Clarity and Presentation scored highly, while Rigour of Development and Applicability scored lowest; diagnostic recommendations showed minor variations.

Conclusions:

  • The quality of guidelines for childhood non-neurogenic DUI is variable.
  • Only two of eight guidelines were recommended for use without adjustments.
  • Guideline developers should utilize tools like AGREE II to enhance quality; clinicians should consider guideline quality in practice.
Abstract